Corbus Pharmaceuticals (NASDAQ:CRBP) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Corbus Pharmaceuticals reported in-line EPS of $-0.08 versus an estimate of $-0.08.
Revenue was down $647.82 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 7.97% increase in the share price the next day.
Here's a look at Corbus Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.11 | -0.11 | -0.12 | -0.15 |
| EPS Actual | -0.08 | -0.02 | -0.15 | -0.14 |
| Revenue Estimate | 350.00K | 650.00K | 870.00K | 960.00K |
| Revenue Actual | 0 | 97.32K | 136.56K | 647.82K |
To track all earnings releases for Corbus Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
